Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Depression and practice guidelines.

John S McIntyre1

  • 1Department of Psychiatry and Behavioral Health, Unity Health System, Rochester, NY 14626, USA.

Human Psychopharmacology
|October 31, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ramaswamy Viswanathan, M.D., Dr.Med.Sc., APA President, 2024-2025.

The American journal of psychiatry·2025
Same author

The revised DGPPN and APA schizophrenia guidelines: Guideline quality and recommendations for long-term antipsychotic treatment.

Schizophrenia research·2020
Same author

The DSM-5 Clinical and Public Health Committee (CPHC): operations, mechanics, controversies and recommendations.

Psychological medicine·2020
Same author

DSM-5 Clinical and Public Health Committee: challenges and considerations.

The American journal of psychiatry·2014
Same author

American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition.

The American journal of psychiatry·2008
Same author

Pedro Ruiz, M.D., 133rd President, 2006-2007.

The American journal of psychiatry·2007

Despite advances in depression treatment, many patients remain undiagnosed or undertreated due to stigma, outdated paradigms, and physician behavior. Evidence-based guidelines aim to improve diagnosis and treatment of this disabling illness.

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Health Services Research

Background:

  • Significant advancements in understanding and treating depression have occurred over the last 20 years.
  • Despite proven efficacy of pharmacological and psychosocial interventions, depression is frequently underdiagnosed and suboptimally treated.
  • Barriers to effective depression care include mental illness stigma, a persistent biomedical model, educational gaps, and time constraints in medical practice.

Purpose of the Study:

  • To highlight the gap between evidence-based depression treatments and clinical practice.
  • To identify reasons for the underdiagnosis and suboptimal treatment of depression.
  • To discuss the role of nomenclature and practice guidelines in improving depression care.

Main Methods:

Related Experiment Videos

  • Review of current understanding and treatment efficacy for depression.
  • Analysis of barriers to diagnosis and treatment in clinical settings.
  • Discussion of potential solutions, including nomenclature and evidence-based guidelines.

    • Main Results:

    • Depression remains a common and disabling illness with a significant treatment gap.
    • Underdiagnosis stems from stigma, biomedical focus, education, and time pressures.
    • Suboptimal treatment is exacerbated by physician behavior and resistance to change.

    Conclusions:

    • Translating advances in depression treatment into practice remains a challenge.
    • Addressing stigma, promoting a biopsychosocial model, and improving physician education are crucial.
    • Criteria-based nomenclature and evidence-based practice guidelines offer a framework for improving depression management.